Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$2.81 - $5.69 $40,003 - $81,002
-14,236 Reduced 26.22%
40,059 $116,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $245,684 - $417,939
-55,210 Reduced 50.42%
54,295 $295,000
Q1 2023

May 15, 2023

SELL
$2.48 - $5.22 $116,016 - $244,196
-46,781 Reduced 29.93%
109,505 $509,000
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $640 - $1,449
-366 Reduced 0.23%
156,286 $353,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $6,961 - $16,807
-2,253 Reduced 1.42%
156,652 $493,000
Q1 2022

May 16, 2022

BUY
$5.07 - $7.2 $73,869 - $104,904
14,570 Added 10.09%
158,905 $955,000
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $615,642 - $927,264
108,579 Added 303.67%
144,335 $928,000
Q3 2021

Nov 15, 2021

BUY
$13.4 - $16.3 $479,130 - $582,822
35,756 New
35,756 $493,000
Q2 2021

Aug 16, 2021

SELL
$14.81 - $19.13 $616,866 - $796,802
-41,652 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$14.52 - $23.53 $604,787 - $980,071
41,652 New
41,652 $741,000
Q4 2020

Feb 16, 2021

SELL
$10.14 - $15.19 $274,398 - $411,056
-27,061 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$9.57 - $21.32 $45,036 - $100,331
4,706 Added 21.05%
27,061 $273,000
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $210,353 - $292,703
-17,228 Reduced 43.52%
22,355 $329,000
Q1 2020

May 15, 2020

SELL
$9.03 - $19.72 $177,809 - $388,306
-19,691 Reduced 33.22%
39,583 $529,000
Q4 2019

Feb 14, 2020

BUY
$13.01 - $17.15 $481,591 - $634,841
37,017 Added 166.32%
59,274 $835,000
Q3 2019

Nov 14, 2019

BUY
$14.55 - $20.56 $323,839 - $457,603
22,257 New
22,257 $363,000
Q2 2018

Aug 14, 2018

SELL
$10.79 - $24.44 $390,867 - $885,339
-36,225 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$9.0 - $20.16 $211,581 - $473,941
23,509 Added 184.88%
36,225 $405,000
Q4 2017

Feb 14, 2018

SELL
$13.26 - $22.86 $47,139 - $81,267
-3,555 Reduced 21.85%
12,716 $247,000
Q3 2017

Nov 14, 2017

BUY
$19.76 - $24.9 $321,514 - $405,147
16,271
16,271 $352,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $620M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.